» Articles » PMID: 26589554

The Relationships of Irisin with Bone Mineral Density and Body Composition in PCOS Patients

Overview
Specialty Endocrinology
Date 2015 Nov 22
PMID 26589554
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Our study aims to assay the irisin level and investigate the relationships of irisin level with body mass index (BMI), body composition and bone metabolism in the polycystic ovary syndrome (PCOS) and control women.

Methods: Fifty two PCOS and 39 control women were recruited. Serum sex hormone, fasting insulin and C-peptide were tested. Fasting serum irisin and adiponectin were measured with enzyme-linked immunosorbent assay. Body composition and bone mineral density were assayed by dual energy X-ray absorptiometry.

Results: Polycystic ovary syndrome women showed different body compositions compared with controls. Serum irisin level of PCOS did not show significant difference compared with controls although it was decreased. The level of adiponectin in PCOS patients was significantly reduced. BMI had no correlation with irisin level. It indicated a positive correlation between serum irisin levels and bone mineral density in the control group and a negative correlation in the PCOS group after BMI and age adjusted. Furthermore, total lean mass has a significant effect on irisin concentration in the PCOS group. There are no correlations between adiponection and body compositions and bone mineral density in both groups.

Conclusions: The abnormal body composition in PCOS may contribute to the circulation irisin. The crosstalk of irisin in different organs was found and may be related to disease development in PCOS.

Citing Articles

Exploring the role of irisin as a potential biomarker in adolescents and young adults with polycystic ovarian syndrome.

Majeed S, Moin H, Shafi R, Fatima S, Zahra T, Zafar S Womens Health (Lond). 2024; 20:17455057241302559.

PMID: 39579119 PMC: 11585921. DOI: 10.1177/17455057241302559.


Serum Irisin in Polycystic Ovary Syndrome and its Alteration with Metformin Intervention.

Telagareddy R, Ravi Kumar P, Pattanaik S, Dash D, Patro D, Sahoo B Indian J Endocrinol Metab. 2024; 28(1):91-97.

PMID: 38533282 PMC: 10962773. DOI: 10.4103/ijem.ijem_379_23.


Association of Fat Mass and Skeletal Muscle Mass with Cardiometabolic Risk Varied in Distinct PCOS Subtypes: A Propensity Score-Matched Case-Control Study.

Cai J, Yue J, Lu N, Li S, Zheng J, Huang R J Clin Med. 2024; 13(2).

PMID: 38256617 PMC: 10817046. DOI: 10.3390/jcm13020483.


Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health.

Mills E, Abbara A, Dhillo W, Comninos A Front Endocrinol (Lausanne). 2023; 14:1163771.

PMID: 37251667 PMC: 10213631. DOI: 10.3389/fendo.2023.1163771.


The Physiological Role of Irisin in the Regulation of Muscle Glucose Homeostasis.

Yano N, Zhao Y, Zhao T Endocrines. 2022; 2(3):266-283.

PMID: 35392577 PMC: 8986094. DOI: 10.3390/endocrines2030025.